# Efavirenz Comparative Bioavailability

> **NCT01704898** · PHASE4 · COMPLETED · sponsor: **Center for Clinical Pharmacology Research Bdbeq S.A.** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Efavirenz 600 Test-Stocrin 600 Reference
- **DRUG:** Stocrin 600 Reference-Efavirenz 600 Test

## Key facts

- **NCT ID:** NCT01704898
- **Lead sponsor:** Center for Clinical Pharmacology Research Bdbeq S.A.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704898, "Efavirenz Comparative Bioavailability". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01704898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*